出生后第一周极早产儿血管升压药的使用
Use of Vasopressors in Extremely Preterm Infants in First Week of Life.
作者信息
Zaveri Parul G, Walker Amanda M, Upadhyay Kirtikumar, Talati Ajay J
机构信息
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
Division of Neonatology, Regional One Health, Memphis, Tennessee.
出版信息
Am J Perinatol. 2023 Apr;40(5):513-518. doi: 10.1055/s-0041-1729558. Epub 2021 May 14.
OBJECTIVE
A significant variability exists for diagnosis and treatment of hypotension in extremely preterm infants. Benefits of the use of vasopressors remain unclear. We wanted to identify the risk factors associated with use of vasopressors in the first week of life and their impact on outcomes of extremely preterm infants.
STUDY DESIGN
Retrospective review of all newborns ≤28 weeks of gestational age (GA) admitted in neonatal intensive care unit from October 1, 2012, to October 31, 2015, done. Data regarding antenatal and neonatal characteristics and outcomes were recorded. Study infants were divided into two cohorts and compared based on vasopressor use. Chi-square, -test, and multiple logistic regression were performed as appropriate and significance set at <0.05.
RESULTS
Of 213 extremely preterm infants, 90 (42.3%) received vasopressors in first week of life. The mean arterial pressure (MAP) at admission in these infants was significantly lower than that of infants who did not require vasopressors (27 ± 8 vs. 30 ± 6 mm Hg, < 0.05). Vasopressors were initiated within 24 hours in 91% of babies. After controlling for other variables, use of vasopressors was significantly higher in infants with lower birth weight (odds ratio [OR]: 3.2, 95% confidence interval [CI]: 1.6-8.3), 5-minute Apgar's score ≤5 (OR: 1.8, 95% CI: 1.2-3.12), and admission hypothermia (OR: 2.7, 95% CI: 1.3-4.9). The use of vasopressors was significantly associated with severe intraventricular hemorrhage (IVH), even after controlling for other significant variables (OR: 5.9, 95% CI: 1.6-9.3).
CONCLUSION
Lower birth weight, low 5-minute Apgar's score, and admission hypothermia are characteristics associated with early use of vasopressors in extremely preterm infants. Infants treated with vasopressors are at a higher risk of developing severe IVH.
KEY POINTS
· Low systemic blood pressure is a very common problem in the extremely preterm population.. · In clinical practice, mean arterial blood pressure (BP) less than the infants GA in week is typically considered to be "low BP.". · About 50% of infants born at <29 weeks of GA received very preterm in the first week of life.. · Use of vasopressors is associated with a higher incidence of intraventricular hemorrhage in extremely preterm population..
目的
极早产儿低血压的诊断和治疗存在显著差异。使用血管升压药的益处仍不明确。我们希望确定与出生后第一周使用血管升压药相关的危险因素及其对极早产儿预后的影响。
研究设计
对2012年10月1日至2015年10月31日入住新生儿重症监护病房的所有胎龄≤28周的新生儿进行回顾性研究。记录产前和新生儿特征及预后数据。将研究婴儿分为两个队列,并根据血管升压药的使用情况进行比较。适当进行卡方检验、t检验和多因素logistic回归分析,设定显著性水平为P<0.05。
结果
在213例极早产儿中,90例(42.3%)在出生后第一周接受了血管升压药治疗。这些婴儿入院时的平均动脉压(MAP)显著低于不需要血管升压药的婴儿(27±8 vs. 30±6 mmHg,P<0.05)。91%的婴儿在24小时内开始使用血管升压药。在控制其他变量后,出生体重较低的婴儿使用血管升压药的比例显著更高(比值比[OR]:3.2,95%置信区间[CI]:1.6-8.3)、5分钟Apgar评分≤5分的婴儿(OR:1.8,95%CI:1.2-3.12)以及入院时体温过低的婴儿(OR:2.7,95%CI:1.3-4.9)。即使在控制其他显著变量后,使用血管升压药仍与严重脑室内出血(IVH)显著相关(OR:5.9,95%CI:1.6-9.3)。
结论
出生体重较低、5分钟Apgar评分低和入院时体温过低是极早产儿早期使用血管升压药的相关特征。接受血管升压药治疗的婴儿发生严重IVH的风险更高。
要点
· 低体循环血压在极早产儿中是一个非常常见的问题。· 在临床实践中,平均动脉血压(BP)低于婴儿胎龄周数通常被认为是“低血压”。· 约50%胎龄<29周出生的婴儿在出生后第一周接受了极早产治疗。· 在极早产儿中,使用血管升压药与脑室内出血的发生率较高相关。